Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2014

Open Access 01-12-2014 | Research

Neurocognitive and neuroinflammatory correlates of PDYN and OPRK1 mRNA expression in the anterior cingulate in postmortem brain of HIV-infected subjects

Authors: Vadim Yuferov, Eduardo R Butelman, Ann Ho, Susan Morgello, Mary Jeanne Kreek

Published in: Journal of Neuroinflammation | Issue 1/2014

Login to get access

Abstract

Chronic inflammation may contribute to neuropsychological impairments in individuals with HIV, and modulation of this inflammatory response by opiate receptor ligands is important in light of the prevalence of drug use in HIV populations. Exogenous MOR and KOR agonists have differential effects on central nervous system (CNS) immunity and, while some data suggest KOR agonists are immunosuppressive, the KOR agonist dynorphin has been shown to stimulate human monocyte chemotaxis. In this study, we examined mRNA levels of endogenous opioid receptors OPRK1 and OPRM1, prodynorphin (PDYN), macrophage scavenger receptor CD163, and microglia/macrophage marker CD68 in the caudate and anterior cingulate of postmortem brains from HIV-positive and HIV-negative subjects. Brain tissues of HIV-infected (n = 24) and control subjects (n = 15) were obtained from the Manhattan HIV Brain Bank. Quantification of the gene mRNA was performed using SYBR Green RT-PCR. CD68 and CD163 were increased in HIV-positive (HIV+) compared to HIV-negative (HIV-) individuals in both brain regions. There were higher OPRK1 (P <0.005), and lower PDYN mRNA (P <0.005) levels in the anterior cingulate of HIV+ compared to HIV- subjects. This difference between the clinical groups was not found in the caudate. There was no difference in the levels of OPRM1 mRNA between HIV+ and HIV- subjects. Using linear regression analysis, we examined the relationship of OPRK1 and PDYN mRNA levels in the HIV+ subjects with seven cognitive domain T scores of a neuropsychological test battery. Within the HIV+ subjects, there was a positive correlation between anterior cingulate PDYN mRNA levels and better T-scores in the motor domain. Within the HIV+ subjects there were also positive correlations of both OPRK1 and PDYN mRNA levels with the anti-inflammatory marker CD163, but not with proinflammatory CD68 levels. In this setting, decreased PDYN mRNA may reflect a homeostatic mechanism to reduce monocyte migration, accompanied by compensatory increases in the cognate receptor (KOR) to dampen pro-inflammatory responses. It is possible that enhanced neuroprotection and better motor performance are associated with higher levels of dynorphin and the recruitment of neuroprotective CD163-positive macrophages. Further studies are needed to test this hypothesis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Woods SP, Moore DJ, Weber E, Grant I: Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009, 19: 152-168. 10.1007/s11065-009-9102-5.PubMedCentralCrossRefPubMed Woods SP, Moore DJ, Weber E, Grant I: Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009, 19: 152-168. 10.1007/s11065-009-9102-5.PubMedCentralCrossRefPubMed
2.
go back to reference Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010, 75: 2087-2096. 10.1212/WNL.0b013e318200d727.PubMedCentralCrossRefPubMed Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010, 75: 2087-2096. 10.1212/WNL.0b013e318200d727.PubMedCentralCrossRefPubMed
3.
go back to reference Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy FA, Mercié P, Greib C, Richert L, Neau D, Catheline G, Dehail P, Dabis F, Morlat P, Dartigues JF, Chêne G: S CO3 Aquitaine cohort: cognitive disorders in HIV-infected patients: are they HIV-related?. AIDS. 2013, 27: 391-400. 10.1097/QAD.0b013e32835b1019.CrossRefPubMed Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy FA, Mercié P, Greib C, Richert L, Neau D, Catheline G, Dehail P, Dabis F, Morlat P, Dartigues JF, Chêne G: S CO3 Aquitaine cohort: cognitive disorders in HIV-infected patients: are they HIV-related?. AIDS. 2013, 27: 391-400. 10.1097/QAD.0b013e32835b1019.CrossRefPubMed
4.
go back to reference Clifford DB: HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med. 2008, 16: 94-98.PubMed Clifford DB: HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med. 2008, 16: 94-98.PubMed
5.
go back to reference Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I: Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol. 1997, 42: 963-972. 10.1002/ana.410420618.CrossRefPubMed Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I: Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol. 1997, 42: 963-972. 10.1002/ana.410420618.CrossRefPubMed
6.
go back to reference Ellis R, Langford D, Masliah E: HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci. 2007, 8: 33-44. 10.1038/nrn2040.CrossRefPubMed Ellis R, Langford D, Masliah E: HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci. 2007, 8: 33-44. 10.1038/nrn2040.CrossRefPubMed
7.
go back to reference Nath A: Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction. Ann N Y Acad Sci. 2010, 1187: 122-128. 10.1111/j.1749-6632.2009.05277.x.CrossRefPubMed Nath A: Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction. Ann N Y Acad Sci. 2010, 1187: 122-128. 10.1111/j.1749-6632.2009.05277.x.CrossRefPubMed
8.
go back to reference Hauser KF, Fitting S, Dever SM, Podhaizer EM, Knapp PE: Opiate drug use and the pathophysiology of neuroAIDS. Curr HIV Res. 2012, 10: 435-452. 10.2174/157016212802138779.PubMedCentralCrossRefPubMed Hauser KF, Fitting S, Dever SM, Podhaizer EM, Knapp PE: Opiate drug use and the pathophysiology of neuroAIDS. Curr HIV Res. 2012, 10: 435-452. 10.2174/157016212802138779.PubMedCentralCrossRefPubMed
9.
go back to reference LaForge KS, Yuferov V, Kreek MJ: Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur J Pharmacol. 2000, 410: 249-268. 10.1016/S0014-2999(00)00819-0.CrossRefPubMed LaForge KS, Yuferov V, Kreek MJ: Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur J Pharmacol. 2000, 410: 249-268. 10.1016/S0014-2999(00)00819-0.CrossRefPubMed
10.
go back to reference Roy S, Wang J, Kelschenbach J, Koodie L, Martin J: Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol. 2006, 1: 77-89. 10.1007/s11481-005-9009-8.CrossRefPubMed Roy S, Wang J, Kelschenbach J, Koodie L, Martin J: Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol. 2006, 1: 77-89. 10.1007/s11481-005-9009-8.CrossRefPubMed
11.
go back to reference Ruff MR, Wahl SM, Mergenhagen S, Pert CB: Opiate receptor-mediated chemotaxis of human monocytes. Neuropeptides. 1985, 5: 363-366. 10.1016/0143-4179(85)90029-0.CrossRefPubMed Ruff MR, Wahl SM, Mergenhagen S, Pert CB: Opiate receptor-mediated chemotaxis of human monocytes. Neuropeptides. 1985, 5: 363-366. 10.1016/0143-4179(85)90029-0.CrossRefPubMed
12.
go back to reference Finley MJ, Chen X, Bardi G, Davey P, Geller EB, Zhang L, Adler MW, Rogers TJ: Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor. J Neuroimmunology. 2008, 197: 114-123. 10.1016/j.jneuroim.2008.04.021.CrossRef Finley MJ, Chen X, Bardi G, Davey P, Geller EB, Zhang L, Adler MW, Rogers TJ: Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor. J Neuroimmunology. 2008, 197: 114-123. 10.1016/j.jneuroim.2008.04.021.CrossRef
13.
go back to reference Byrd D, Murray J, Safdieh G, Morgello S: Impact of opiate addiction on neuroinflammation in HIV. J Neurovirol. 2012, 18: 364-373. 10.1007/s13365-012-0118-x.PubMedCentralCrossRefPubMed Byrd D, Murray J, Safdieh G, Morgello S: Impact of opiate addiction on neuroinflammation in HIV. J Neurovirol. 2012, 18: 364-373. 10.1007/s13365-012-0118-x.PubMedCentralCrossRefPubMed
14.
go back to reference Kreek MJ, LaForge KS, Butelman E: Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002, 1: 710-726. 10.1038/nrd897.CrossRefPubMed Kreek MJ, LaForge KS, Butelman E: Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002, 1: 710-726. 10.1038/nrd897.CrossRefPubMed
15.
16.
go back to reference Pfeiffer A, Brantl V, Herz A, Emrich HM: Psychotomimesis mediated by kappa opiate receptors. Science. 1986, 233: 774-776. 10.1126/science.3016896.CrossRefPubMed Pfeiffer A, Brantl V, Herz A, Emrich HM: Psychotomimesis mediated by kappa opiate receptors. Science. 1986, 233: 774-776. 10.1126/science.3016896.CrossRefPubMed
17.
go back to reference Dykstra LA, Gmerek DE, Winger G, Woods JH: Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther. 1987, 242: 413-420.PubMed Dykstra LA, Gmerek DE, Winger G, Woods JH: Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther. 1987, 242: 413-420.PubMed
18.
go back to reference Butelman ER, Prisinzano TE, Deng H, Rus S, Kreek MJ: Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid. J Pharmacol Exp Ther. 2009, 328: 588-597. 10.1124/jpet.108.145342.PubMedCentralCrossRefPubMed Butelman ER, Prisinzano TE, Deng H, Rus S, Kreek MJ: Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid. J Pharmacol Exp Ther. 2009, 328: 588-597. 10.1124/jpet.108.145342.PubMedCentralCrossRefPubMed
19.
go back to reference Redell JB, Moore AN, Dash PK: Expression of the prodynorphin gene after experimental brain injury and its role in behavioral dysfunction. Exp Biol Med (Maywood). 2003, 228: 261-269. Redell JB, Moore AN, Dash PK: Expression of the prodynorphin gene after experimental brain injury and its role in behavioral dysfunction. Exp Biol Med (Maywood). 2003, 228: 261-269.
20.
go back to reference Loacker S, Sayyah M, Wittmann W, Herzog H, Schwarzer C: Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors. Brain. 2007, 130: 1017-1028.CrossRefPubMed Loacker S, Sayyah M, Wittmann W, Herzog H, Schwarzer C: Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors. Brain. 2007, 130: 1017-1028.CrossRefPubMed
21.
go back to reference Schunk E, Aigner C, Stefanova N, Wenning G, Herzog H, Schwarzer C: Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection. Hippocampus. 2011, 21: 1010-1020.PubMed Schunk E, Aigner C, Stefanova N, Wenning G, Herzog H, Schwarzer C: Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection. Hippocampus. 2011, 21: 1010-1020.PubMed
22.
go back to reference McIntosh TK, Fernyak S, Yamakami I, Faden AI: Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats. Am J Physiol. 1994, 267: R665-R672.PubMed McIntosh TK, Fernyak S, Yamakami I, Faden AI: Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats. Am J Physiol. 1994, 267: R665-R672.PubMed
23.
go back to reference Chao CC, Gekker G, Hu S, Sheng WS, Shark KB, Bu DF, Archer S, Bidlack JM, Peterson PK: Kappa opioid receptors in human microglia downregulate human HIV-1 expression. Proc Natl Acad Sci USA. 1996, 93: 8051-8056. 10.1073/pnas.93.15.8051.PubMedCentralCrossRefPubMed Chao CC, Gekker G, Hu S, Sheng WS, Shark KB, Bu DF, Archer S, Bidlack JM, Peterson PK: Kappa opioid receptors in human microglia downregulate human HIV-1 expression. Proc Natl Acad Sci USA. 1996, 93: 8051-8056. 10.1073/pnas.93.15.8051.PubMedCentralCrossRefPubMed
24.
go back to reference Peterson PK, Gekker G, Lokensgard JR, Bidlack JM, Chang AC, Fang X, Portoghese PS: Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes. Biochem Pharmacol. 2001, 61: 1145-1151. 10.1016/S0006-2952(01)00574-3.CrossRefPubMed Peterson PK, Gekker G, Lokensgard JR, Bidlack JM, Chang AC, Fang X, Portoghese PS: Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes. Biochem Pharmacol. 2001, 61: 1145-1151. 10.1016/S0006-2952(01)00574-3.CrossRefPubMed
25.
go back to reference Sheng WS, Hu S, Lokensgard JR, Peterson PK: U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol. 2003, 65: 9-14. 10.1016/S0006-2952(02)01480-6.CrossRefPubMed Sheng WS, Hu S, Lokensgard JR, Peterson PK: U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol. 2003, 65: 9-14. 10.1016/S0006-2952(02)01480-6.CrossRefPubMed
26.
go back to reference Chao CC, Gekker G, Hu S, Sheng WS, Portoghese PS, Peterson P: Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem Pharmacol. 1995, 50: 715-722. 10.1016/0006-2952(95)00176-Z.CrossRefPubMed Chao CC, Gekker G, Hu S, Sheng WS, Portoghese PS, Peterson P: Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem Pharmacol. 1995, 50: 715-722. 10.1016/0006-2952(95)00176-Z.CrossRefPubMed
27.
go back to reference Mathieu-Kia AM, Fan LQ, Kreek MJ, Simon EJ, Hiller JM: Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer’s disease patients. Brain Res. 2001, 893: 121-134. 10.1016/S0006-8993(00)03302-3.CrossRefPubMed Mathieu-Kia AM, Fan LQ, Kreek MJ, Simon EJ, Hiller JM: Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer’s disease patients. Brain Res. 2001, 893: 121-134. 10.1016/S0006-8993(00)03302-3.CrossRefPubMed
28.
go back to reference Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M: Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol. 2000, 14: 222-227. 10.1177/026988110001400305.CrossRefPubMed Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M: Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol. 2000, 14: 222-227. 10.1177/026988110001400305.CrossRefPubMed
29.
go back to reference Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M: Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neurovirol. 2011, 17: 26-40. 10.1007/s13365-010-0003-4.CrossRefPubMed Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M: Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neurovirol. 2011, 17: 26-40. 10.1007/s13365-010-0003-4.CrossRefPubMed
30.
go back to reference Devinsky O, Morrell MJ, Vogt BA: Contributions of anterior cingulate cortex to behavior. Brain. 1995, 118: 279-306. 10.1093/brain/118.1.279.CrossRefPubMed Devinsky O, Morrell MJ, Vogt BA: Contributions of anterior cingulate cortex to behavior. Brain. 1995, 118: 279-306. 10.1093/brain/118.1.279.CrossRefPubMed
31.
go back to reference Febvret A, Berger B, Gaspar P, Verney C: Further indication that distinct dopaminergic subsets project to the rat cerebral cortex: lack of colocalization with neurotensin in the superficial dopaminergic fields of the anterior cingulate, motor, retrosplenial and visual cortices. Brain Res. 1991, 547: 37-52.CrossRefPubMed Febvret A, Berger B, Gaspar P, Verney C: Further indication that distinct dopaminergic subsets project to the rat cerebral cortex: lack of colocalization with neurotensin in the superficial dopaminergic fields of the anterior cingulate, motor, retrosplenial and visual cortices. Brain Res. 1991, 547: 37-52.CrossRefPubMed
32.
go back to reference Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH, Soukup VM: Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol. 2012, 7: 686-700. 10.1007/s11481-012-9345-4.PubMedCentralCrossRefPubMed Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH, Soukup VM: Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol. 2012, 7: 686-700. 10.1007/s11481-012-9345-4.PubMedCentralCrossRefPubMed
33.
go back to reference Yuferov V, Ho A, Morgello S, Yang Y, Ott J, Kreek MJ: Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment. J Neuroimmune Pharmacol. 2013, 8: 333-344. 10.1007/s11481-012-9429-1.PubMedCentralCrossRefPubMed Yuferov V, Ho A, Morgello S, Yang Y, Ott J, Kreek MJ: Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment. J Neuroimmune Pharmacol. 2013, 8: 333-344. 10.1007/s11481-012-9429-1.PubMedCentralCrossRefPubMed
34.
go back to reference Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK: Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004, 26: 759-778. 10.1080/13803390490509565.CrossRefPubMed Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK: Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004, 26: 759-778. 10.1080/13803390490509565.CrossRefPubMed
35.
go back to reference Rose’Meyer RB, Mellick AS, Garnham BG, Harrison GJ, Massa HM, Griffiths LR: The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res Brain Res Protoc. 2003, 11: 9-18. 10.1016/S1385-299X(02)00219-2.CrossRefPubMed Rose’Meyer RB, Mellick AS, Garnham BG, Harrison GJ, Massa HM, Griffiths LR: The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res Brain Res Protoc. 2003, 11: 9-18. 10.1016/S1385-299X(02)00219-2.CrossRefPubMed
36.
go back to reference Peckys D, Hurd Y: Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders. Brain Res Bull. 2001, 55: 619-624. 10.1016/S0361-9230(01)00525-1.CrossRefPubMed Peckys D, Hurd Y: Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders. Brain Res Bull. 2001, 55: 619-624. 10.1016/S0361-9230(01)00525-1.CrossRefPubMed
37.
go back to reference Schwarzer C: 30 years of dynorphins–new insights on their functions in neuropsychiatric diseases. Pharmacol Ther. 2009, 123: 353-370. 10.1016/j.pharmthera.2009.05.006.PubMedCentralCrossRefPubMed Schwarzer C: 30 years of dynorphins–new insights on their functions in neuropsychiatric diseases. Pharmacol Ther. 2009, 123: 353-370. 10.1016/j.pharmthera.2009.05.006.PubMedCentralCrossRefPubMed
38.
go back to reference Shukla VK, Lemaire S: Non-opioid effects of dynorphins: possible role of the NMDA receptor. Trends Pharmacol Sci. 1994, 15: 420-424. 10.1016/0165-6147(94)90091-4.CrossRefPubMed Shukla VK, Lemaire S: Non-opioid effects of dynorphins: possible role of the NMDA receptor. Trends Pharmacol Sci. 1994, 15: 420-424. 10.1016/0165-6147(94)90091-4.CrossRefPubMed
39.
go back to reference Singh IN, Goody RJ, Goebel SM, Martin KM, Knapp PE, Marinova Z, Hirschberg D, Yakovleva T, Bergman T, Bakalkin G, Hauser KF: Dynorphin A (1–17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation. Neuroscience. 2003, 122: 1013-1023. 10.1016/j.neuroscience.2003.08.033.CrossRefPubMed Singh IN, Goody RJ, Goebel SM, Martin KM, Knapp PE, Marinova Z, Hirschberg D, Yakovleva T, Bergman T, Bakalkin G, Hauser KF: Dynorphin A (1–17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation. Neuroscience. 2003, 122: 1013-1023. 10.1016/j.neuroscience.2003.08.033.CrossRefPubMed
40.
go back to reference Voorn P, van de Witte SV, Li K, Jonker AJ: Dynorphin displaces binding at the glycine site of the NMDA receptor in the rat striatum. Neurosci Lett. 2007, 415: 55-58. 10.1016/j.neulet.2006.12.041.CrossRefPubMed Voorn P, van de Witte SV, Li K, Jonker AJ: Dynorphin displaces binding at the glycine site of the NMDA receptor in the rat striatum. Neurosci Lett. 2007, 415: 55-58. 10.1016/j.neulet.2006.12.041.CrossRefPubMed
41.
go back to reference Solbrig MV, Adrian R, Baratta J, Lauterborn JC, Koob GF: Kappa opioid control of seizures produced by a virus in an animal model. Brain. 2006, 129: 642-654. 10.1093/brain/awl008.CrossRefPubMed Solbrig MV, Adrian R, Baratta J, Lauterborn JC, Koob GF: Kappa opioid control of seizures produced by a virus in an animal model. Brain. 2006, 129: 642-654. 10.1093/brain/awl008.CrossRefPubMed
42.
go back to reference Carta A, Fenu S, Morelli M: Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson’s disease. Neurol Sci. 2001, 22: 59-60. 10.1007/s100720170046.CrossRefPubMed Carta A, Fenu S, Morelli M: Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson’s disease. Neurol Sci. 2001, 22: 59-60. 10.1007/s100720170046.CrossRefPubMed
43.
go back to reference Solbrig MV, Koob GF: Epilepsy, CNS viral injury and dynorphin. Trends Pharmacol Sci. 2004, 25: 98-104. 10.1016/j.tips.2003.12.010.CrossRefPubMed Solbrig MV, Koob GF: Epilepsy, CNS viral injury and dynorphin. Trends Pharmacol Sci. 2004, 25: 98-104. 10.1016/j.tips.2003.12.010.CrossRefPubMed
44.
go back to reference Hussain ZB, Fitting S, Watanabe H, Usynin I, Yakovleva T, Knapp PE, Scheff SW, Hauser KF, Bakalkin G: Lateralized Response of Dynorphin A Peptide Levels after Traumatic Brain Injury. J Neurotrauma. 2012, 29: 1785-1793. 10.1089/neu.2011.2286.PubMedCentralCrossRefPubMed Hussain ZB, Fitting S, Watanabe H, Usynin I, Yakovleva T, Knapp PE, Scheff SW, Hauser KF, Bakalkin G: Lateralized Response of Dynorphin A Peptide Levels after Traumatic Brain Injury. J Neurotrauma. 2012, 29: 1785-1793. 10.1089/neu.2011.2286.PubMedCentralCrossRefPubMed
45.
go back to reference Sun B, Tipton CM, Bidlack JM: The expression of prodynorphin gene is down-regulated by activation with lipopolysaccharide in U-937 macrophage cells. J Neuroimmunol. 2006, 174: 52-62. 10.1016/j.jneuroim.2006.01.006.CrossRefPubMed Sun B, Tipton CM, Bidlack JM: The expression of prodynorphin gene is down-regulated by activation with lipopolysaccharide in U-937 macrophage cells. J Neuroimmunol. 2006, 174: 52-62. 10.1016/j.jneuroim.2006.01.006.CrossRefPubMed
46.
go back to reference Gabrilovac J, Cupić B, Zapletal E, Brozovic A: IFN-γ up-regulates κ opioid receptors (KOR) on murine macrophage cell line J774. J Neuroimmunol. 2012, 245: 56-65. 10.1016/j.jneuroim.2012.02.006.CrossRefPubMed Gabrilovac J, Cupić B, Zapletal E, Brozovic A: IFN-γ up-regulates κ opioid receptors (KOR) on murine macrophage cell line J774. J Neuroimmunol. 2012, 245: 56-65. 10.1016/j.jneuroim.2012.02.006.CrossRefPubMed
47.
go back to reference Puehler W, Rittner HL, Mousa SA, Brack A, Krause H, Stein C, Schäfer M: Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation. Neuroscience. 2006, 141: 989-998. 10.1016/j.neuroscience.2006.03.078.CrossRefPubMed Puehler W, Rittner HL, Mousa SA, Brack A, Krause H, Stein C, Schäfer M: Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation. Neuroscience. 2006, 141: 989-998. 10.1016/j.neuroscience.2006.03.078.CrossRefPubMed
48.
go back to reference Soares HD, Hicks RR, Smith D, McIntosh TK: Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci. 1995, 15: 8223-8233.PubMed Soares HD, Hicks RR, Smith D, McIntosh TK: Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci. 1995, 15: 8223-8233.PubMed
49.
50.
go back to reference Wang Q, Shin EJ, Nguyen XK, Li Q, Bach JH, Bing G, Kim WK, Kim HC, Hong JS: Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice. J Neuroinflammation. 2012, 9: 124-10.1186/1742-2094-9-124.PubMedCentralCrossRefPubMed Wang Q, Shin EJ, Nguyen XK, Li Q, Bach JH, Bing G, Kim WK, Kim HC, Hong JS: Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice. J Neuroinflammation. 2012, 9: 124-10.1186/1742-2094-9-124.PubMedCentralCrossRefPubMed
51.
go back to reference Srinivasan L, Asaad WF, Ginat DT, Gale JT, Dougherty DD, Williams ZM, Sejnowski TJ, Eskandar EN: Action initiation in the human dorsal anterior cinulate cortex. PLoS One. 2013, 8: e55247-10.1371/journal.pone.0055247.PubMedCentralCrossRefPubMed Srinivasan L, Asaad WF, Ginat DT, Gale JT, Dougherty DD, Williams ZM, Sejnowski TJ, Eskandar EN: Action initiation in the human dorsal anterior cinulate cortex. PLoS One. 2013, 8: e55247-10.1371/journal.pone.0055247.PubMedCentralCrossRefPubMed
52.
go back to reference Palomero-Gallagher N, Mohlberg H, Zilles K, Vogt B: Cytology and receptor architecture of human anterior cingulate cortex. J Comp Neurol. 2008, 508: 906-926. 10.1002/cne.21684.PubMedCentralCrossRefPubMed Palomero-Gallagher N, Mohlberg H, Zilles K, Vogt B: Cytology and receptor architecture of human anterior cingulate cortex. J Comp Neurol. 2008, 508: 906-926. 10.1002/cne.21684.PubMedCentralCrossRefPubMed
Metadata
Title
Neurocognitive and neuroinflammatory correlates of PDYN and OPRK1 mRNA expression in the anterior cingulate in postmortem brain of HIV-infected subjects
Authors
Vadim Yuferov
Eduardo R Butelman
Ann Ho
Susan Morgello
Mary Jeanne Kreek
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2014
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-11-5

Other articles of this Issue 1/2014

Journal of Neuroinflammation 1/2014 Go to the issue